MEDANTA.NS Profit & Loss
Global Health Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 22:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹2,694.25 Cr. | ₹3,275.11 Cr. | ₹3,692.32 Cr. | ₹4,410.27 Cr. | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹64.91 Cr. | ₹74.66 Cr. | ₹79.10 Cr. | ₹98.59 Cr. | OtherIncome |
| Total Income | ₹2,759.16 Cr. | ₹3,349.78 Cr. | ₹3,771.41 Cr. | ₹4,508.86 Cr. | Income |
| Cost of Materials Consumed | ₹571.12 Cr. | ₹687.69 Cr. | ₹789.96 Cr. | ₹882.13 Cr. | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹55.74 Cr. | ₹73.97 Cr. | ₹92.46 Cr. | ₹117.30 Cr. | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-1.58 Cr. | ₹-2.29 Cr. | ₹-2.75 Cr. | ₹-2.63 Cr. | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹634.35 Cr. | ₹734.86 Cr. | ₹824.54 Cr. | ₹1,096.11 Cr. | EmployeeBenefitExpense |
| Finance Costs | ₹77.92 Cr. | ₹73.91 Cr. | ₹65.26 Cr. | ₹79.11 Cr. | FinanceCosts |
| Depreciation and Amortisation | ₹149.91 Cr. | ₹172.73 Cr. | ₹193.75 Cr. | ₹222.54 Cr. | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹822.41 Cr. | ₹981.82 Cr. | ₹1,111.04 Cr. | ₹1,398.26 Cr. | OtherExpenses |
| Total Expenses | ₹2,309.87 Cr. | ₹2,722.68 Cr. | ₹3,074.26 Cr. | ₹3,792.82 Cr. | Expenses |
| Profit Before Exceptional Items and Tax | ₹449.29 Cr. | ₹627.10 Cr. | ₹697.15 Cr. | ₹716.04 Cr. | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Cr. | ₹0.00 Cr. | ₹-49.90 Cr. | ₹-1.02 Cr. | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹449.29 Cr. | ₹627.10 Cr. | ₹647.26 Cr. | ₹715.02 Cr. | ProfitBeforeTax |
| Tax Expense | ₹123.21 Cr. | ₹149.04 Cr. | ₹165.94 Cr. | ₹160.95 Cr. | TaxExpense |
| Net Profit (incl. minority interest) | ₹326.08 Cr. | ₹478.06 Cr. | ₹481.32 Cr. | ₹554.07 Cr. | ProfitLossForPeriod |
| Net Profit (to shareholders) | N/A | ₹478.19 Cr. | ₹481.44 Cr. | ₹556.46 Cr. | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹12.58 | ₹17.80 | ₹17.92 | ₹20.71 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹12.57 | ₹17.80 | ₹17.92 | ₹20.66 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from MEDANTA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).